Skip to content

Ginkgo Bioworks DNA Net Change in Cash

Net Change in Cash at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
-$6.6B-5,099%
Charles River Laboratories logo
Charles River LaboratoriesCRL
-$17.8M-168%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$51.45M-1,849%
TEC
Bio-TechneTECH
$36.94M+200%
Azenta logo
AzentaAZTA
-$102.7M+18.2%
Regenxbio logo
RegenxbioRGNX
-$19.24M-127%

Other financials

Income statement

See full
Revenue$19.5M-49.1%
Gross profit$16.4M-52.0%
Operating income-$71.4M+11.9%
Net income-$82.6M+9.2%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$188.7M-46.9%
Total debt$410.7M-5.5%
Total equity$443.2M-31.6%
Total assets$1.0B-20.1%

Cash flow

See full
Operating cash flow-$46.7M+9.4%
CapEx$1.9M-74.6%
Free cash flow-$48.6M+17.8%

Valuation

See full
Market cap$625.16M+24.6%
Enterprise value$847.19M+45.9%
P/S4.4×+2.2×

Profitability

See full
Operating margin-210.7%+7.6pp
Net margin-215.4%+8.3pp
FCF margin-119%-21.2pp

Returns & leverage

See full
Return on equity-55.8%-1.8pp
Debt / equity0.9×+0.3×
Current ratio5.2×+0.3×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ginkgo Bioworks's net change in cash?
Ginkgo Bioworks (DNA) reported net change in cash of -$23.7M in Q1 2026.
How has Ginkgo Bioworks's net change in cash changed year-over-year?
Ginkgo Bioworks's net change in cash increased by 90.5% year-over-year, from -$250.34M to -$23.7M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.